FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2559986370> ?p ?o ?g. }

• W2559986370 abstract "Abstract In this prospective study we examined the use of an intensified conditioning regimen followed by allogeneic blood-stem-cell transplantation (BSCT) for the treatment of young adults in physically good condition with relapsed or high risk acute lymphoblastic leukaemia (ALL). Eleven patients with ALL received FLAMSA chemotherapy (fludarabine 30mg/m2 - cytarabine 2000mg/m2 -amsacrine 100 mg/m2 on day −10, − 9, − 8and −7), Anti-Thymocyte-Globulin (ATG 20 mg/kg BW on day −6, −5 and −4) and fractionated TBI (2 x 2 Gy on day −3, − 2 and −1) followed by matched unrelated donor (n=10) or matched sibling donor (n=1) SCT. The principle reasons for high risk stratification were refractory disease during first-line induction therapy (6, 55%), relapse (2, 18%), extramedullary disease manifestation (1, 9%), ALL subtype (6, 55%), unfavorable cytogenetics (5, 45%) and white blood count >30000 μL at time of diagnosis (3, 27%). After a median follow-up time of 604 days (range 202 – 1042 days) 8 patients (73%) are alive and 3 patients (27%) died. The median overall survival was not reached. Two patients died after relapse on days +121 and +449, another patient died from treatment related complications (HUS-TTP) on day +87. One patient relapsed on day +200 and is currently alive, the remaining 7 patients are alive and free of desease. Treatment related toxicities were acceptable. With 6 out of 11 patients developing grade III/IV infections during neutropenia, infectious complications remained of major importance. Other non-haematological side effects seen within this group of patients were less frequent and almost exclusively limited to gastrointestinal toxicities. Five patients (45%) had grade III/IV mucositis and 5 patients (45%) had grade III/IV nausea, while 4 patients (36%) showed grade III/IV diarrhoea. There was no case of acute toxicity related to the cardiavascular or central nervous system. The incidence of acute GvHD (aGvHD) was 36% (n = 4) and limited to grades II-III. Eight patients were evaluable for chronic GvHD (cGvHD). Out of those 4 patients (36%) developed cGvHD (3 limited disease, 1 extensive disease). We conclude that allogeneic transplatation after the FLAMSA-ATG-TBI regimen is feasible and provides effective therapy for this group of high-risk patients." @default.
• W2559986370 created "2016-12-16" @default.
• W2559986370 creator A5001433615 @default.
• W2559986370 creator A5049125906 @default.
• W2559986370 creator A5050035884 @default.
• W2559986370 creator A5055012214 @default.
• W2559986370 creator A5074257446 @default.
• W2559986370 creator A5083308570 @default.
• W2559986370 creator A5090048856 @default.
• W2559986370 date "2007-11-16" @default.
• W2559986370 modified "2023-09-29" @default.
• W2559986370 title "Fludarabine, Amsacrine, High-Dose Cytarabine and Total Body Irridation Followed by Allogeneic Stem Cell Transplantation for the Treatment of High Risk or Relapsed Acute Lymphoblastic Leukemia." @default.
• W2559986370 doi "https://doi.org/10.1182/blood.v110.11.5086.5086" @default.
• W2559986370 hasPublicationYear "2007" @default.
• W2559986370 type Work @default.
• W2559986370 sameAs 2559986370 @default.
• W2559986370 citedByCount "0" @default.
• W2559986370 crossrefType "journal-article" @default.
• W2559986370 hasAuthorship W2559986370A5001433615 @default.
• W2559986370 hasAuthorship W2559986370A5049125906 @default.
• W2559986370 hasAuthorship W2559986370A5050035884 @default.
• W2559986370 hasAuthorship W2559986370A5055012214 @default.
• W2559986370 hasAuthorship W2559986370A5074257446 @default.
• W2559986370 hasAuthorship W2559986370A5083308570 @default.
• W2559986370 hasAuthorship W2559986370A5090048856 @default.
• W2559986370 hasConcept C126322002 @default.
• W2559986370 hasConcept C141071460 @default.
• W2559986370 hasConcept C2776694085 @default.
• W2559986370 hasConcept C2776755627 @default.
• W2559986370 hasConcept C2777063308 @default.
• W2559986370 hasConcept C2777408962 @default.
• W2559986370 hasConcept C2778041864 @default.
• W2559986370 hasConcept C2778119113 @default.
• W2559986370 hasConcept C2778461978 @default.
• W2559986370 hasConcept C2779263901 @default.
• W2559986370 hasConcept C2780500152 @default.
• W2559986370 hasConcept C2781107101 @default.
• W2559986370 hasConcept C2781413609 @default.
• W2559986370 hasConcept C2909962599 @default.
• W2559986370 hasConcept C2911091166 @default.
• W2559986370 hasConcept C71924100 @default.
• W2559986370 hasConcept C90924648 @default.
• W2559986370 hasConceptScore W2559986370C126322002 @default.
• W2559986370 hasConceptScore W2559986370C141071460 @default.
• W2559986370 hasConceptScore W2559986370C2776694085 @default.
• W2559986370 hasConceptScore W2559986370C2776755627 @default.
• W2559986370 hasConceptScore W2559986370C2777063308 @default.
• W2559986370 hasConceptScore W2559986370C2777408962 @default.
• W2559986370 hasConceptScore W2559986370C2778041864 @default.
• W2559986370 hasConceptScore W2559986370C2778119113 @default.
• W2559986370 hasConceptScore W2559986370C2778461978 @default.
• W2559986370 hasConceptScore W2559986370C2779263901 @default.
• W2559986370 hasConceptScore W2559986370C2780500152 @default.
• W2559986370 hasConceptScore W2559986370C2781107101 @default.
• W2559986370 hasConceptScore W2559986370C2781413609 @default.
• W2559986370 hasConceptScore W2559986370C2909962599 @default.
• W2559986370 hasConceptScore W2559986370C2911091166 @default.
• W2559986370 hasConceptScore W2559986370C71924100 @default.
• W2559986370 hasConceptScore W2559986370C90924648 @default.
• W2559986370 hasLocation W25599863701 @default.
• W2559986370 hasOpenAccess W2559986370 @default.
• W2559986370 hasPrimaryLocation W25599863701 @default.
• W2559986370 hasRelatedWork W2064930805 @default.
• W2559986370 hasRelatedWork W2083765864 @default.
• W2559986370 hasRelatedWork W2148592690 @default.
• W2559986370 hasRelatedWork W2235490402 @default.
• W2559986370 hasRelatedWork W2306571443 @default.
• W2559986370 hasRelatedWork W2347837139 @default.
• W2559986370 hasRelatedWork W2373000763 @default.
• W2559986370 hasRelatedWork W2373928853 @default.
• W2559986370 hasRelatedWork W2559986370 @default.
• W2559986370 hasRelatedWork W4231819935 @default.
• W2559986370 isParatext "false" @default.
• W2559986370 isRetracted "false" @default.
• W2559986370 magId "2559986370" @default.
• W2559986370 workType "article" @default.